From the Journals

Ibalizumab shows promise against MDR HIV-1

Ibalizumab can not only help decrease viral loads in patients with multidrug-resistant HIV type 1, but it also can help increase CD4 counts.

FDA/CDC

CDC supports Ebola response in DRC

The CDC is coordinating with the Democratic Republic of the Congo on a new Ebola outbreak in North Kivu province...

Pages